WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2005016278) ANTIBIOTIC PRODUCT, USE AND FORMULATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/016278 International Application No.: PCT/US2004/026175
Publication Date: 24.02.2005 International Filing Date: 12.08.2004
Chapter 2 Demand Filed: 09.03.2005
IPC:
A61K 9/20 (2006.01) ,A61K 9/50 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
48
Preparations in capsules, e.g. of gelatin, of chocolate
50
Microcapsules
Applicants: BURNSIDE, Beth, A.[US/US]; US (UsOnly)
FLANNER, Henry, H.[US/US]; US (UsOnly)
ROWLINGS, Colin[US/US]; US (UsOnly)
ADVANCIS PHARMACEUTICALS CORPORATION[US/US]; 20425 Seneca Meadows Parkway Germantown, MD 20876, US (AllExceptUS)
Inventors: BURNSIDE, Beth, A.; US
FLANNER, Henry, H.; US
ROWLINGS, Colin; US
Agent: STAUFFER, Raymond, E. ; Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein 5 Becker Farm Road Roseland, NJ 07068, US
Priority Data:
60/494,45412.08.2003US
Title (EN) ANTIBIOTIC PRODUCT, USE AND FORMULATION THEREOF
(FR) ANTIBIOTIQUE, UTILISATION ET FORMULATION ASSOCIEES
Abstract:
(EN) An antibiotic product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antibiotic product being reached in less than about twelve hours after the initial release of antibiotic. In one embodiment, there is a delayed release dosage form, as well as two or more delayed sustained release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
(FR) L'invention concerne un antibiotique comportant au moins trois formes posologiques ayant chacune un profil de libération différent, le Cmax de l'antibiotique étant atteint en moins de douze heures environ après la libération initiale de l'antibiotique. Dans un mode de réalisation, l'antibiotique comprend une forme posologique à action retardée et deux formes posologiques ou plus à action différée et prolongée, chaque forme posologique ayant un profil de libération différent et atteignant un Cmax à des moments différents.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)